Floatz logo

scg142

HPV-Related Squamous Cell Carcinoma

SCG Cell Therapy Pte. Ltd.Cell therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the HPV-Related Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Christian Hinrichs
Phase 2B
Fludarabine
Christian Hinrichs
Phase 2B
e7 tcr-t cells
Christian Hinrichs
Phase 2B
9-valent human papillomavirus recombinant vaccine
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3B
Retifanlimab
Jennifer Dorth
Phase 2CCC

View all 18 →

Same molecule, other indications

scg142 is also rated in:

cervical squamous cell carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
vaginal squamous cell carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
head and neck cancerDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →